{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:16:14Z","timestamp":1790007374529,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872334"],"award-info":[{"award-number":["81872334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.redox.2023.102608","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T02:05:04Z","timestamp":1673834704000},"page":"102608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Synergistic effect of glutathione and IgG4 in immune evasion and the implication for cancer immunotherapy"],"prefix":"10.1016","volume":"60","author":[{"given":"Weifeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangli","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muwang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.102608_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"issue":"5844","key":"10.1016\/j.redox.2023.102608_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.redox.2023.102608_bib3","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.0804338","article-title":"Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions","volume":"182","author":"Rispens","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.redox.2023.102608_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.redox.2023.102608_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000661","article-title":"An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.redox.2023.102608_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1880687","article-title":"IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer","volume":"10","author":"Jordakieva","year":"2021","journal-title":"OncoImmunology"},{"issue":"4","key":"10.1016\/j.redox.2023.102608_bib7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1172\/JCI65579","article-title":"IgG4 subclass antibodies impair antitumor immunity in melanoma","volume":"123","author":"Karagiannis","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.redox.2023.102608_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145017","article-title":"The role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer","volume":"21","author":"Bianchini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.redox.2023.102608_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"issue":"7","key":"10.1016\/j.redox.2023.102608_bib10","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"issue":"13","key":"10.1016\/j.redox.2023.102608_bib11","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-18-3527","article-title":"LKB1 and KEAP1\/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma","volume":"79","author":"Galan-Cobo","year":"2019","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.redox.2023.102608_bib12","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1158\/1078-0432.CCR-16-3133","article-title":"Hyperprogressors after immunotherapy: analysis of genomic alterations associated with accelerated growth rate","volume":"23","author":"Kato","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.redox.2023.102608_bib13","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jtho.2019.05.033","article-title":"Comprehensive clinical and genetic characterization of hyperprogression based on volumetry in advanced non-small cell lung cancer treated with immune checkpoint inhibitor","volume":"14","author":"Kim","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.redox.2023.102608_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2018.09.019","article-title":"LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and gamma-irradiation","volume":"156","author":"Zulato","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.redox.2023.102608_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.molcel.2016.04.033","article-title":"Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53","volume":"62","author":"Riscal","year":"2016","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.redox.2023.102608_bib16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.redox.2023.102608_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41571-018-0111-2","article-title":"Hyperprogressive disease: recognizing a novel pattern to improve patient management","volume":"15","author":"Champiat","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.redox.2023.102608_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-18-1390","article-title":"Antibody-fc\/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non-small cell lung cancer subsequent to PD-1\/PD-L1 blockade","volume":"25","author":"Lo Russo","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.redox.2023.102608_bib19","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1021\/ja203638y","article-title":"Mechanism of immunoglobulin G4 Fab-arm exchange","volume":"133","author":"Rispens","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.redox.2023.102608_bib20","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.redox.2023.102608_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/wrr.12445","article-title":"A new method for skin grafting in murine model","volume":"24","author":"Pakyari","year":"2016","journal-title":"Wound Repair Regen."},{"issue":"1\u20132","key":"10.1016\/j.redox.2023.102608_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molimm.2012.06.012","article-title":"Fc-Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer","volume":"53","author":"Rispens","year":"2013","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.redox.2023.102608_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-5890(01)00050-5","article-title":"The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds %","volume":"38","author":"Schuurman","year":"2001","journal-title":"J Mol Immunol"},{"key":"10.1016\/j.redox.2023.102608_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.redox.2017.03.030","article-title":"Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms","volume":"12","author":"Zhang","year":"2017","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.redox.2023.102608_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/labinvest.3700407","article-title":"Thiol-reactive compounds prevent nonspecific antibody binding in immunohistochemistry","volume":"86","author":"Rogers","year":"2006","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.redox.2023.102608_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/039463201102400108","article-title":"Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications","volume":"24","author":"Perricone","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"9","key":"10.1016\/j.redox.2023.102608_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8090413","article-title":"Glutathione induced immune-stimulatory activity by promoting M1-like macrophages polarization via potential ROS scavenging capacity","volume":"8","author":"Kwon","year":"2019","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.redox.2023.102608_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13635","article-title":"IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance","volume":"74","author":"Bianchini","year":"2019","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.redox.2023.102608_bib29","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.4049\/jimmunol.1401409","article-title":"IgG4 and IgE transcripts in childhood allergic asthma reflect divergent antigen-driven selection","volume":"193","author":"Rogosch","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.redox.2023.102608_bib30","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00436-019-06451-2","article-title":"IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a Fc-Fc-dependent mechanism","volume":"118","author":"Prodjinotho","year":"2019","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.redox.2023.102608_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11882-016-0600-2","article-title":"Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions","volume":"16","author":"James","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"2","key":"10.1016\/j.redox.2023.102608_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2010.07.014","article-title":"Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma","volume":"305","author":"Kim","year":"2011","journal-title":"Cancer Lett."},{"issue":"30","key":"10.1016\/j.redox.2023.102608_bib33","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3748\/wjg.v25.i30.4148","article-title":"Colorectal cancer surveillance in inflammatory bowel disease: practice guidelines and recent developments","volume":"25","author":"Clarke","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.redox.2023.102608_bib34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.redox.2023.102608_bib35","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3899\/jrheum.150436","article-title":"Association between immunoglobulin G4-related disease and malignancy within 12 Years after diagnosis: an analysis after longterm Followup","volume":"42","author":"Asano","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.redox.2023.102608_bib36","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.redox.2023.102608_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4161\/19420862.2014.975657","article-title":"IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcgammaRI","volume":"6","author":"Swisher","year":"2014","journal-title":"mAbs"},{"issue":"10","key":"10.1016\/j.redox.2023.102608_bib38","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1128\/IAI.00136-08","article-title":"Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress","volume":"76","author":"Kariya","year":"2008","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.redox.2023.102608_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1399-3003.2000.016003534.x","article-title":"Oxidative stress and regulation of glutathione in lung inflammation","volume":"16","author":"Rahman","year":"2000","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.redox.2023.102608_bib40","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1096\/fj.201701157R","article-title":"Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells","volume":"32","author":"Miran","year":"2018","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.redox.2023.102608_bib41","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1021\/acsnano.9b08347","article-title":"Weak fragment crystallizable (Fc) domain interactions drive the dynamic assembly of IgG oligomers upon antigen recognition","volume":"14","author":"Strasser","year":"2020","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.redox.2023.102608_bib42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/19420862.2019.1664365","article-title":"Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development","volume":"11","author":"Dumet","year":"2019","journal-title":"mAbs"},{"issue":"12","key":"10.1016\/j.redox.2023.102608_bib43","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/jps.24620","article-title":"Comprehensive analysis of the therapeutic IgG4 antibody Pembrolizumab: hinge modification blocks half molecule exchange in vitro and in vivo","volume":"104","author":"Yang","year":"2015","journal-title":"J Pharm Sci"},{"issue":"21","key":"10.1016\/j.redox.2023.102608_bib44","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1200\/JCO.20.03579","article-title":"Pembrolizumab plus Ipilimumab or placebo for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score \u2265 50%: randomized, double-blind phase III KEYNOTE-598 study","volume":"39","author":"Boyer","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.redox.2023.102608_bib45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1470-2045(21)00136-4","article-title":"Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial","volume":"22","author":"Sacco","year":"2021","journal-title":"Lancet Oncol."},{"issue":"28","key":"10.1016\/j.redox.2023.102608_bib46","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced non\u2012small-cell lung cancer treated with Pembrolizumab: results from the phase I KEYNOTE-001 study","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.redox.2023.102608_bib47","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2014.58.3708","article-title":"Overall survival and long-term safety of Nivolumab (Anti-Programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer","volume":"33","author":"Gettinger","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.redox.2023.102608_bib48","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/jamaoncol.2018.3676","article-title":"Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy","volume":"4","author":"Ferrara","year":"2018","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.redox.2023.102608_bib49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1","volume":"23","author":"Champiat","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.redox.2023.102608_bib50","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/annonc\/mdx178","article-title":"Hyperprogression during anti-PD-1\/PD-L1 therapy in patients with recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"28","author":"Saada-Bouzid","year":"2017","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.redox.2023.102608_bib51","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jamaoncol.2020.1634","article-title":"Clarification of definitions of hyperprogressive disease during immunotherapy for non-small cell lung cancer","volume":"6","author":"Kas","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.redox.2023.102608_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2016.10.010","article-title":"Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers","volume":"102","author":"Chapman","year":"2016","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.redox.2023.102608_bib53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.redox.2023.102608_bib54","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1016\/j.jtho.2018.08.481","article-title":"MA19.10 impact of STK11\/LKB1 genomic alterations on clinical outcomes with chemo-immunotherapy in non-squamous NSCLC","volume":"13","author":"Skoulidis","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"10","key":"10.1016\/j.redox.2023.102608_bib55","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1016\/j.jtho.2018.08.480","article-title":"MA19.09 concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB","volume":"13","author":"Arbour","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.redox.2023.102608_bib56","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat Med"},{"issue":"6266","key":"10.1016\/j.redox.2023.102608_bib57","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.redox.2023.102608_bib58","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/TP.0000000000001069","article-title":"B cells and antibodies in transplantation","volume":"100","author":"Koenig","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.redox.2023.102608_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2015.02.004","article-title":"The perfect storm: HLA antibodies, complement, FcgammaRs, and endothelium in transplant rejection","volume":"21","author":"Thomas","year":"2015","journal-title":"Trends Mol. Med."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:31:42Z","timestamp":1761978702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":59,"alternative-id":["S2213231723000095"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.102608","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of glutathione and IgG4 in immune evasion and the implication for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.102608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102608"}}